Most Commented
- Cubadebate opens its new Web page in English| 20
- Mandela is dead: Why hide the truth about Apartheid?| 11
- El Paso Diary: The Battle Over the Solo Fax| 10
- President Hugo Chavez's address to the People of Venezuela| 10
- Free the Five is heard at Left Forum| 6
- May every citizen be a constituent| 6
- Raúl receives Kim Yong Chol, Special Envoy of the President of the Workers’ Party of Korea| 6
- The Unsustainable Position of the Empire| 5
- U.S. government promoting Internet aggression against Cuba| 5
- NATO’s Genocidal Role| 4
- The Fiftieth Anniversary Parade| 4
- El Paso Diary: The Tip of the Iceberg| 4
Series
- Cuba's Reasons
- Cuban Five
- El Paso Diary
The El Paso Diary is written by José Pertierra--an attorney who represents the government of Venezuela in its request for the extradition of Luis Posada Carriles. Pertierra´s journals describe the testimony, evidence, legal skirmishes, quirks and follies of this very historic trial that features for the first time the close collaboration of the United States government with Cuban authorities to prosecute an ex CIA agent who is one of the masterminds of the fifty-year old dirty war against Cuba.
Authors
- Bernie Dwyer
- Bruno Rodríguez Parrilla
- Deisy Francis Mexidor
- Fidel Castro Ruz
- José Pertierra
- Raúl Castro Ruz
- Ricardo Alarcón de Quesada
- Amy Goodman
- Arleen Rodríguez Derivet
- Frei Betto
- Hugo Chávez Frías
- Josh R. Nelson
- Juan Gelman
- Luis Rumbaut
- Michael Moore
- Mumia Abu-Jamal
- Noam Chomsky
- Reinaldo Taladrid Herrero
- Richard Gott
- Tom Hayden
Articles of Biotechnology
News »
Investments to expand production of bioproducts in Cuba
Rooted in Fidel’s wisdom, like almost everything good between heaven and earth in Cuba, the use of bioproducts in agriculture dates back to the 1990s, when four production plants, located in the municipalities of Güira de Melena, Güines, Matanzas and Sancti Spíritus, saw the light of day under the guidance of our Comandante en jefe. Engineer Teobaldo Cruz Méndez, lead investment specialist at the Labiofam State Enterprise Management Group (OSDE).
News »
Vaccination against selfishness and inequality
Solidarity and Justice are still words in disuse even when the catastrophe concerns us all, like a great universal Titanic. A tiny and sticky virus has moved fears, shaken societies and health systems, provoked countless reflections on today and the future, but it has not succeeded in making equity and love for others prosper. This week will mark the 100 millionth person infected with COVID-19 in the world and already more than 2 million people have died.
News »
The emergence of Soberana 1 is not a chance event
Since the beginning of the Revolution, the priority granted to scientific progress, with emphasis on the training of highly qualified human capital and the creation of research centers in dissimilar branches of knowledge, were essential prerequisites that allowed Cuba to venture into the promising sector of biotechnology in the decade of the 1980s, practically at the same time this industry was emerging in a small group of nations with greater technological development.
News »
BioCen develops secure medium to transport viral samples, a first in Cuba
Researchers at the National Biopreparations Center (BioCen) have developed Cuba’s first secure medium to transport viruses, created for use in the collection and transfer of patients’ nasopharyngeal and oropharyngeal samples for the diagnosis of SARS-COV-2, the COVID-19 causal agent. BioCen achieved and industrially scaled the product in only seven days and, subsequently received its Sanitary Registration from the State Center for the Control of Drugs, Equipment and Medical Devices (Cecmed).
News »
The Cuban pharmaceutical industry vs COVID-19
The Cuban pharmaceutical industry has been key to the national strategy to confront the SARS-COV-2 pandemic, guaranteeing medications to implement treatment protocols established by the Ministry of Public Health (Minsap), including several products used successfully with high-risk segments of the population, reducing the number of patients reaching serious and critical conditions, as well as mortality rates for this group.
News »
BioFarma Innovations, a new joint enterprise created by BioCubaFarma and SG Innovations Limited
The new partnership aims to provide broader access to BioCubaFarma’s patent-protected portfolio of biopharmaceutical products, developed by the pharmaceutical and biotechnology industry in Cuba. Cuba’s BioCubaFarma Enterprise Group and the British company SG Innovations Limited has announced the creation of a new company, BioFarma Innovations focused on accelerating the development of new medications and their distribution in Europe and the British Commonwealth.
News »
Cuban drug approved to treat COVID-19 in India
India’s Drug Regulatory Authority has approved exceptional use of the Cuban drug Itolizumab to treat severe patients with COVID-19, reported Eduardo Ojito Magaz, director of Cuba’s Molecular Immunology Center (CIM), on Twitter. Winner of a National Prize from the Cuban Academy of Sciences in 2014, this humanized monoclonal antibody has been part of the medical care protocol for COVID-19 in Cuba since April.
News »
Efficiency: a challenge for the pharmaceutical industry
To ensure stability in the basic supply of medications and reduce shortages, on April 8, President Miguel Díaz-Canel Bermúdez called for greater efforts to replace imports with domestic products and incorporate new ones; diversify markets and meet with export projections; while strengthening the investment process – despite the complex financial context – to increase productive capacity.
News »
A new milestone in Cuban biotechnology
The development of Cuban biotechnology has reached another important milestone with the recent signing of an agreement to establish a Cuba-United States joint venture enterprise to produce and distribute a therapeutic cancer medication.